The goal of this between-participants parallel randomized controlled trial conducted in the Systembolaget mobile application is to investigate the impact of exposure to health messages on cognition and behaviour. The primary study objective is to examine whether repeated exposure to rotating health warning messages in a mobile app where customers can purchase alcoholic beverages influences the number of purchased units of alcohol over the studied period. The secondary objectives are to examine whether repeated exposure to health warning messages in a mobile app influences the number of alcoholic and non-alcoholic products purchased over the studied period, knowledge of alcohol-related harms, alcohol-related risk perceptions, emotional response to the message, engagement with the messages, behavioural intentions and self-reported behaviour of the study participants. Users of the app providing informed consent for participation in the study will be assigned either to an experimental group, where they will be exposed to rotating messages describing health risks associated with alcohol designed in line with the existing Swedish regulation, or to a control group that will be exposed to messages reflecting existing industry practice. The intervention will last for ten weeks, during which the recruited participants' data on product purchases in the app will be collected through in-app analytics. Both the number of alcoholic units and number of products purchased per session will be assessed and compared at the session level between the two groups. At the end of the intervention, participants will complete a short survey examining their knowledge, risk perceptions, emotional response, engagement with the messages, intentions and behaviour.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
11,719
Textual health warning messages currently mandated for use in printed alcohol advertisements under the Swedish Alcohol Ordinance, focusing on communicated various alcohol harms
Pictograms indicating no alcohol use during pregnancy and while driving
Systembolaget mobile app
Stockholm, Sweden
Number of purchased units of alcohol
Alcohol units will be calculated based on product-specific information on alcohol by volume (ABV) and volume purchased. The calculations will be made for the overall purchases and separately by type of beverage (beer, wine, spirits, other).
Time frame: From enrolment to the end of the intervention period at 10 weeks
Number of individual purchased products
For overall purchases and separately by type of beverage (beer, wine, spirits, other, non-alcoholic beverages)
Time frame: From enrolment to the end of the intervention period at 10 weeks.
Knowledge of alcohol-related harms
Will be assessed with question "Which of the following diseases and conditions does alcohol consumption increase the risk of? (select all that apply)", with the possible choices being \[Cancer, Heart Disease , Liver Disease, Respiratory Disease, Alcohol use disorder, Injuries, Diabetes, Pancreatitis, Multiple sclerosis, Cerebral haemorrhage, Fetal alcohol spectrum disorder\] displayed randomly, and "I don't know" and "None" as exclusive options. The question format and options were adapted from a previous study \[18\], but expanded with a longer list of possible outcomes described in the used health messages. Two outcomes will be derived from this question: (i) the correct identification of the conditions mentioned in the messages, with the possible score range being between 0 and 7 points, and (ii) the correct identification of cancer as condition that alcohol increases risk of.
Time frame: End of 10 week intervention period
Self-reported behaviour
Alcohol consumption behaviour will be based on question on whether they have foregone an alcoholic drink because they wanted to drink less and whether they have ever replaced alcoholic beverage with a non-alcoholic alternative because they wanted to drink less alcohol.
Time frame: End of 10 week intervention period
Risk perception
Perceived personal cancer risk will be measured with the question "If I consume alcohol on a regular basis, I am at greater risk of getting cancer." Perceived general health risk will be measured with the question "If I consume more alcohol, I am at greater risk for health harm". Both questions will be measured on 5-point Likert scale (Strongly Disagree to Strongly Agree).
Time frame: End of 10 week intervention period
Intention
Intention will be measured with the question "I intend to cut down on the number of alcohol units that I drink in the next month" on 5-point Likert scale (Strongly Disagree to Strongly Agree).
Time frame: End of 10 week intervention period
Emotional response
Emotional response will only be measured among those reporting to have noticed the warnings, "Thinking about messages I've seen as part of this study, I felt: disgusted / afraid / uncomfortable / worried / excited / pleased, with Likert answers scale from 1 to 5 (1 = Not at all, 3 = Moderately, and 5 = Very).
Time frame: End of 10 week intervention period
Engagement with messages
* Noticing, reading and recalling the warnings: Participants will be asked if they noticed health-related messages while using the Systembolaget app in the past two months. Participants will also be presented with a list of statements and asked to mark which of those have they been exposed to during participation in the study. * Information seeking behaviour: If participants noticed the health messages, they will be asked if they took any actions such as searching for more information about health risks, discussing the information with others, or looking for ways to reduce their alcohol consumption. * Message perceptions: Participants who noticed the health messages will also be asked to indicate their level of agreement with statements about the impact of the information on their alcohol consumption, purchasing behaviour, and their perception of the information's acceptability, novelty, relevance, and believability. Responses will be measured on a 5-point Likert scale.
Time frame: End of 10 week intervention period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.